Ensysce Biosciences, Inc (ENSC) Social Stream



Ensysce Biosciences, Inc (ENSC): $8.10

0.15 (+1.89%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add ENSC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#140 of 334

in industry

ENSYSCE BIOSCIENCES INC (ENSC) Price Targets From Analysts

Use the tables below to see what analysts covering ENSYSCE BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 1 $4 $4 $4 $1.15 247.83%
2022-04-06 1 $23 $4 $13.5 $1.15 1073.91%
2022-05-17 1 $11 $4 $7.5 $1.15 552.17%
2022-10-25 1 $12 $4 $8 $1.15 595.65%
2022-11-16 1 $240 $80 $160 $1.15 13813.04%
2022-11-17 1 $240 $8 $124 $1.15 10682.61%
2022-12-08 1 $8 $5.3 $6.65 $1.15 478.26%
2023-02-07 1 $96.038 $43.817 $69.927 $1.15 5980.61%
2023-04-03 1 $96.038 $43.8 $69.919 $1.15 5979.91%
2023-04-12 1 $43.8 $15 $29.4 $1.15 2456.52%
2023-05-09 1 $17.25 $15 $16.125 $1.15 1302.17%
2023-05-16 1 $17.85 $15 $16.425 $1.15 1328.26%
2023-08-11 2 $17.85 $9 $13.95 $1.15 1113.04%
2023-09-25 2 $17.85 $7 $13.283 $1.15 1055.04%
2023-11-10 2 $17.5 $7 $13.166 $1.15 1044.87%
NA 1 $NA $NA $NA $1.15 NA%

The Trend in the Analyst Price Target


ENSC's average price target has moved down $3.26 over the prior 178 days.

ENSC reports an average of 1,496.43% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-03 1 96.038 43.8 69.919 4.70 1387.64%
2023-05-16 2 17.850 15.0 16.425 2.97 453.03%
2023-08-08 2 17.850 9.0 13.950 1.89 638.1%
2023-08-11 2 17.850 9.0 13.950 1.90 634.21%
2023-09-25 2 17.850 7.0 13.283 1.45 816.07%

ENSC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


ENSC's average broker recommendation rating improved by 0 over the prior 48 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ENSC as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, ENSYSCE BIOSCIENCES INC's number of analysts covering the stock is greater than 11.32% of them.
  • In terms of how ENSYSCE BIOSCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1647.77% of that group.
  • ENSYSCE BIOSCIENCES INC's variance in analysts' estimates is lower than -985.7% of stocks in the small market cap category.
  • To contextualize these metrics, consider that out of Healthcare stocks, ENSYSCE BIOSCIENCES INC's average analyst price target is greater than 589.06% of them.

Stocks similar to ENSYSCE BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NRXP, NCNA, and ATNF.

Make investment decisions regarding ENSC using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!